ACUTE LEUKEMIA
Clinical trials for ACUTE LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new ACUTE LEUKEMIA trials appear
Sign up with your email to follow new studies for ACUTE LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Targeted radiation before transplant could give leukemia patients a fighting chance
Disease control Not yet recruitingThis study tests a new approach for people with relapsed or refractory acute myeloid leukemia (AML) who have active disease. Before a stem cell transplant, patients receive a targeted radiation drug (131I-apamistamab) along with standard chemotherapy and low-dose whole-body radia…
Matched conditions: ACUTE LEUKEMIA
Phase: PHASE2, PHASE3 • Sponsor: Actinium Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 10:29 UTC
-
New transplant recipe aims to cut Graft-Versus-Host disease in blood cancer patients
Disease control Not yet recruitingThis early-phase study tests a new combination of chemotherapy drugs (thiotepa, busulfan, fludarabine) followed by a lower dose of post-transplant cyclophosphamide for stem cell transplants in people with blood cancers like leukemia and myelodysplastic syndrome. The goal is to re…
Matched conditions: ACUTE LEUKEMIA
Phase: PHASE1 • Sponsor: Sawa Ito, MD • Aim: Disease control
Last updated May 26, 2026 10:26 UTC
-
New drug QUAIL-100 tested in kids with tough leukemia after transplant
Disease control Not yet recruitingThis early-stage study tests a new drug, QUAIL-100, for safety in 12 children and young adults with high-risk acute leukemia or myelodysplastic syndrome who have already had a special type of stem cell transplant. The goal is to see if the drug is safe and to find the right dose.…
Matched conditions: ACUTE LEUKEMIA
Phase: PHASE1 • Sponsor: Laguna Biotherapeutics, Inc. • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
New CAR-T therapy made inside the body could cut costs for blood cancer patients
Disease control Not yet recruitingThis early-stage study tests a new type of CAR-T cell therapy that is made inside the body, avoiding the expensive and complex lab process normally needed. It targets two proteins (CD19 and BAFF-R) on cancer cells in people with relapsed or hard-to-treat B-cell acute leukemia or …
Matched conditions: ACUTE LEUKEMIA
Phase: PHASE1 • Sponsor: Qi deng • Aim: Disease control
Last updated May 06, 2026 16:14 UTC